5.975
price down icon0.25%   -0.015
after-market Dopo l'orario di chiusura: 6.01 0.035 +0.59%
loading

Tenax Therapeutics Inc Azioni (TENX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
-24.40 9.2378 7.344 -
Operating Expenses
55.43%
11.34
7.2948 4.6189 3.672 3.9083
Operating Income/Loss
64.23%
-11.34
-31.69 4.6189 3.672 -3.9083
Income/Loss From Continuing Operations Before Tax
66.08%
-10.41
-6.267 3.9605 -3.5757 -3.7988
Income/Loss From Continuing Operations After Tax
66.08%
-10.41
-6.267 3.9605 -3.5757 -3.7988
Net Income/Loss
66.08%
-10.41
-6.267 3.9605 -3.5757 -3.7988
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
100.00%
-
22.67 - - -
Basic Average Shares
36.58
- - - -
Diluted Average Shares
36.58
- - - -
Basic Earnings Per Share
-0.28
- - - -
Diluted Earnings Per Share
-0.28
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.89
price up icon 4.10%
$85.98
price up icon 1.62%
$23.84
price up icon 0.59%
$100.62
price up icon 0.62%
$145.30
price up icon 6.76%
biotechnology ONC
$332.04
price up icon 8.49%
Capitalizzazione:     |  Volume (24 ore):